Related Experiment Videos
The search for the CD8+ cell anti-HIV factor (CAF)
1University of California, San Francisco, Department of Medicine, 513 Parnassus, S1280, Box 1270, San Francisco, CA 94143-1270, USA. jalevy@itsa.ucsf.edu
Trends in Immunology
|December 3, 2003
Summary
Long-term HIV survivors control the virus naturally through innate immunity, specifically the CD8(+) cell antiviral non-cytotoxic response (CNAR) mediated by a CD8(+) cell antiviral factor (CAF). Research is identifying these natural anti-HIV factors.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Antiretroviral drugs control HIV replication but are not a long-term solution.
- Long-term non-progressors (LTNP) maintain health without treatment, indicating natural immune control of HIV.
- Innate immunity, particularly CD8(+) cell responses, plays a crucial role in controlling HIV in LTNP.
Purpose of the Study:
- To describe the characteristics of the CD8(+) cell antiviral non-cytotoxic response (CNAR) and the associated CD8(+) cell antiviral factor (CAF).
- To review progress in identifying the specific CAF involved in natural HIV control.
- To explore the relationship between CAF and other identified natural anti-HIV factors.
Main Methods:
- Characterization of CNAR and CAF mechanisms in LTNP.
- Review of studies focused on identifying the molecular nature of CAF.
- Comparative analysis of CAF with other natural anti-HIV factors.
Main Results:
- The CD8(+) cell antiviral non-cytotoxic response (CNAR) is a key immune mechanism in long-term non-progressors.
- A novel CD8(+) cell antiviral factor (CAF) mediates this non-cytotoxic antiviral response.
- Several natural anti-HIV factors have been uncovered, with ongoing investigation into their link to CAF.
Conclusions:
- Innate immune mechanisms, including CNAR and CAF, are critical for natural HIV control in some individuals.
- Understanding CAF and related factors offers potential for novel therapeutic strategies against HIV.
- Further research into these natural anti-HIV factors could lead to new avenues for HIV management.